CN110540958B - 脐带间充质干细胞分泌因子的制备及其在生发中的应用 - Google Patents
脐带间充质干细胞分泌因子的制备及其在生发中的应用 Download PDFInfo
- Publication number
- CN110540958B CN110540958B CN201910276760.8A CN201910276760A CN110540958B CN 110540958 B CN110540958 B CN 110540958B CN 201910276760 A CN201910276760 A CN 201910276760A CN 110540958 B CN110540958 B CN 110540958B
- Authority
- CN
- China
- Prior art keywords
- stem cell
- umbilical cord
- mesenchymal stem
- cord mesenchymal
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 51
- 210000003954 umbilical cord Anatomy 0.000 title claims abstract description 48
- 230000003248 secreting effect Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims description 11
- 230000003779 hair growth Effects 0.000 title description 9
- 210000000130 stem cell Anatomy 0.000 claims abstract description 42
- 230000006698 induction Effects 0.000 claims abstract description 36
- 210000003780 hair follicle Anatomy 0.000 claims abstract description 26
- 239000002609 medium Substances 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000006228 supernatant Substances 0.000 claims abstract description 12
- 230000003660 hair regeneration Effects 0.000 claims abstract description 7
- 230000008439 repair process Effects 0.000 claims abstract description 7
- 239000012879 subculture medium Substances 0.000 claims abstract description 7
- 230000001737 promoting effect Effects 0.000 claims abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 30
- 239000001963 growth medium Substances 0.000 claims description 19
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 15
- 102000004877 Insulin Human genes 0.000 claims description 15
- 108090001061 Insulin Proteins 0.000 claims description 15
- 102000004338 Transferrin Human genes 0.000 claims description 15
- 108090000901 Transferrin Proteins 0.000 claims description 15
- 229930003268 Vitamin C Natural products 0.000 claims description 15
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 15
- 229940125396 insulin Drugs 0.000 claims description 15
- 229960001471 sodium selenite Drugs 0.000 claims description 15
- 235000015921 sodium selenite Nutrition 0.000 claims description 15
- 239000011781 sodium selenite Substances 0.000 claims description 15
- 239000012581 transferrin Substances 0.000 claims description 15
- 235000019154 vitamin C Nutrition 0.000 claims description 15
- 239000011718 vitamin C Substances 0.000 claims description 15
- 210000004027 cell Anatomy 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 8
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims description 7
- 229960003632 minoxidil Drugs 0.000 claims description 7
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 5
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 5
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 201000004384 Alopecia Diseases 0.000 description 10
- 239000007640 basal medium Substances 0.000 description 10
- 210000004209 hair Anatomy 0.000 description 10
- 229920001184 polypeptide Polymers 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 230000028327 secretion Effects 0.000 description 10
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 9
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000003676 hair loss Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000008157 ELISA kit Methods 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 206010068168 androgenetic alopecia Diseases 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229960004039 finasteride Drugs 0.000 description 3
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000003803 hair density Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
- 101000808007 Mus musculus Vascular endothelial growth factor A Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000009583 hair follicle growth Effects 0.000 description 2
- 230000003662 hair growth rate Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000003658 preventing hair loss Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000000442 hair follicle cell Anatomy 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004216 mammary stem cell Anatomy 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 108010088102 mouse insulin-like growth factor-1 Proteins 0.000 description 1
- 210000002894 multi-fate stem cell Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
观察项目\观察日 | 首日 | 2天后 | 4周 | 4周+2天后 | 8周 | 8周+2天后 |
受试者到访 | ○ | ○ | ○ | ○ | ○ | ○ |
试验说明和取得同意 | ○ | - | - | - | - | - |
皮肤镜图像分析管理系统 | ○ | ○ | ○ | ○ | ○ | ○ |
剃发 | ○ | - | ○ | - | ○ | - |
全头拍照 | - | ○ | - | ○ | - | ○ |
受试者自我评估 | - | ○ | - | ○ | - | ○ |
确认试验样品的使用状况 | - | ○ | - | ○ | - | ○ |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910276760.8A CN110540958B (zh) | 2019-04-08 | 2019-04-08 | 脐带间充质干细胞分泌因子的制备及其在生发中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910276760.8A CN110540958B (zh) | 2019-04-08 | 2019-04-08 | 脐带间充质干细胞分泌因子的制备及其在生发中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110540958A CN110540958A (zh) | 2019-12-06 |
CN110540958B true CN110540958B (zh) | 2021-09-03 |
Family
ID=68702672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910276760.8A Active CN110540958B (zh) | 2019-04-08 | 2019-04-08 | 脐带间充质干细胞分泌因子的制备及其在生发中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110540958B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112980796A (zh) * | 2019-12-17 | 2021-06-18 | 东莞市东阳光生物药研发有限公司 | 用于降低cho细胞中表达重组蛋白的氧化的液体培养基 |
CN111228311A (zh) * | 2020-03-02 | 2020-06-05 | 陕西朗泰生物科技有限公司 | 保护和诱导毛囊再生的干细胞生发因子的制备方法 |
CN114681486B (zh) * | 2020-12-30 | 2024-05-10 | 杭州易文赛生物技术有限公司 | 一种干细胞因子组合物及其在毛发再生中的用途 |
CN115572709A (zh) * | 2022-10-18 | 2023-01-06 | 中晶生物技术股份有限公司 | 三维培养间充质干细胞微球在制备脱发修复与再生药物或制剂中的应用 |
WO2024107102A1 (en) * | 2022-11-17 | 2024-05-23 | Cellresearch Corporation Pte. Ltd. | Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration |
CN115537393B (zh) * | 2022-12-05 | 2023-03-17 | 广州优特佳生物科技发展有限公司 | 一种促进毛发生长的脐带间充质干细胞定向分泌组的制备方法和应用 |
CN116920069B (zh) * | 2023-07-06 | 2024-05-17 | 廊坊康宝汇泰生物技术有限公司 | 一种中药提取液及其在促进脐带干细胞分泌vegf中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104164405A (zh) * | 2014-08-12 | 2014-11-26 | 赛业(苏州)生物科技有限公司 | 一种高效的体外培养人脐带间质干细胞的无血清培养体系 |
CN109464374A (zh) * | 2018-11-23 | 2019-03-15 | 北京安溢生物科技有限公司 | 脐带间充质干细胞因子复合物在促进头发再生中的应用 |
-
2019
- 2019-04-08 CN CN201910276760.8A patent/CN110540958B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104164405A (zh) * | 2014-08-12 | 2014-11-26 | 赛业(苏州)生物科技有限公司 | 一种高效的体外培养人脐带间质干细胞的无血清培养体系 |
CN109464374A (zh) * | 2018-11-23 | 2019-03-15 | 北京安溢生物科技有限公司 | 脐带间充质干细胞因子复合物在促进头发再生中的应用 |
Non-Patent Citations (2)
Title |
---|
VEGF gene transfected umbilical cord mesenchymal stem cells transplantation improve the lower limb vascular lesions of diabetic rats;Xiaoling Li等;《J Diabetes Complications》;20150502;第29卷(第7期);参见全文 * |
血管紧张素Ⅱ对人脐带间充质干细胞生物学特性的影响;杨靖等;《中华损伤与修复杂志(电子版)》;20151001;第10卷(第5期);参见全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN110540958A (zh) | 2019-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110540958B (zh) | 脐带间充质干细胞分泌因子的制备及其在生发中的应用 | |
US20210220256A1 (en) | Hair growth promoting capacity of conditioned media of stimulated stem cells and use thereof | |
KR101462004B1 (ko) | 탯줄 추출물의 제조방법 및 그의 용도 | |
Roh et al. | The hair growth promoting effect of Sophora flavescens extract and its molecular regulation | |
Liu et al. | Direct comparison of the potency of human mesenchymal stem cells derived from amnion tissue, bone marrow and adipose tissue at inducing dermal fibroblast responses to cutaneous wounds | |
Chunmeng et al. | Effects of dermal multipotent cell transplantation on skin wound healing | |
CN108699519A (zh) | 干细胞衍生的含有大量生长因子的外来体 | |
CN106659741B (zh) | 小尺寸干细胞的毛发生长促进功能及其用途 | |
US20130172252A1 (en) | Methods for promoting hair growth | |
KR101779932B1 (ko) | 나노그(Nanog)를 도입한 양수 내 태아 유래 중간엽 줄기세포를 이용한 육모 촉진용 조성물의 제조방법 | |
CN110191714A (zh) | 制备用于毛发生长的组合物的方法,该组合物包含从引入了nanog的羊水中胎儿衍生间充质干细胞获得的外泌体 | |
CN114699446A (zh) | 一种用于治疗脱发的外泌体复合液及其制备方法 | |
KR100802144B1 (ko) | 탈모 방지 또는 모발성장 촉진용 조성물 | |
KR101425653B1 (ko) | 인간 지방조직 유래 다분화능 줄기세포 및 모낭세포를함유하는 세포치료제 | |
CN1878530A (zh) | 用于毛发增粗的方法和组合物 | |
Choi et al. | Generation of trichogenic adipose-derived stem cells by expression of three factors | |
US20120003186A1 (en) | Method for dedifferentiating adipose tissue stromal cells | |
WO2009111087A1 (en) | Novel use of basic fibroblast growth factor in the de-differentiation of animal connective tissue cells | |
KR101656511B1 (ko) | 육모 및 탈모방지능이 개선된 지방줄기세포 배양액 및 그의 제조방법 | |
KR101032271B1 (ko) | 피부세포 재생용 조성물, 그 제조 방법, 피부세포 재생 방법 및 화장료 조성물 | |
JP7015518B2 (ja) | 毛包幹細胞の未分化状態維持剤 | |
KR102124272B1 (ko) | Hb-egf를 유효성분으로 포함하는 지방줄기세포의 발모능 증진용 조성물 | |
EP3903793A1 (en) | Pharmaceutical composition comprising clonal stem cell for prevention or treatment of atopic dermatitis | |
Zhou et al. | A novel experimental study on establish a myoblasts differentiated cell sheet using induced adipose-derived stem cell technology | |
Oliva et al. | Tenogenic potential of equine fetal mesenchymal stem cells under the in vitro effect of bone morphogenetic protein-12 (BMP-12) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Room 14F1401-B, 705 Asia-Pacific Road, Nanhu District, Jiaxing City, Zhejiang Province, 314000 Applicant after: Enlightenment Hemei Biotechnology (Jiaxing) Co.,Ltd. Address before: Room 14F1401-B, 705 Asia-Pacific Road, Nanhu District, Jiaxing City, Zhejiang Province, 314000 Applicant before: TUS-HEALCARE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 314000 room 14f1401-b, No. 705, Asia Pacific Road, Nanhu District, Jiaxing City, Zhejiang Province Applicant after: Hemei Biotechnology (Zhejiang) Co.,Ltd. Address before: 314000 room 14f1401-b, No. 705, Asia Pacific Road, Nanhu District, Jiaxing City, Zhejiang Province Applicant before: Enlightenment Hemei Biotechnology (Jiaxing) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of secreted factor from umbilical cord mesenchymal stem cells and its application in hair growth Effective date of registration: 20221109 Granted publication date: 20210903 Pledgee: Zhejiang Tailong Commercial Bank Co.,Ltd. Jiaxing Branch Pledgor: Hemei Biotechnology (Zhejiang) Co.,Ltd. Registration number: Y2022980021280 |